Literature DB >> 111881

Activation of the alternative pathway of human complement by haemoglobin.

W A Wilson, E J Thomas.   

Abstract

Haemoglobin solutions (concentration greater than 1.5 mg/ml), prepared from lysates of erythrocytes from a normal subject and from a patient with sickle cell anaemia, caused factor B and C3 cleavage and loss of haemolytic activity of factor B wehn incubated with fresh autologous serum. Under the same experimental conditions, preparations of erythrocyte stroma or of buffycoat lysates did not produce factor B and C3 cleavage. This reaction required Mg++ but not C1q or C4, indicating that the alternative complement pathway was activated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 111881      PMCID: PMC1537709     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.

Authors:  C B LAURELL
Journal:  Anal Biochem       Date:  1965-02       Impact factor: 3.365

2.  Deficiency of factor B of the complement system in sickle cell anaemia.

Authors:  W A Wilson; G R Hughes; P J Lachmann
Journal:  Br Med J       Date:  1976-02-14

3.  Serum opsonization of salmonella in sickle cell anemia.

Authors:  W L Hand; N L King
Journal:  Am J Med       Date:  1978-03       Impact factor: 4.965

4.  Complement activation in asymptomatic patients with sickle cell anaemia.

Authors:  W A Wilson; E J Thomas; J G Sissons
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

5.  Activation of the alternate pathway of human complements by rabbit cells.

Authors:  T A Platts-Mills; K Ishizaka
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

6.  Activation of human complement by glutaraldehyde-treated red cells.

Authors:  N C Hughes-Jones; B Gardner; J Rowlands
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

7.  Plasma hemoglobin and hemoglobin fractions in sickle cell crisis.

Authors:  H N Naumann; L W Diggs; L Barreras; B J Williams
Journal:  Am J Clin Pathol       Date:  1971-08       Impact factor: 2.493

8.  An abnormality of the alternate pathway of complement activation in sickle-cell disease.

Authors:  R B Johnston; S L Newman; A G Struth
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

9.  Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.

Authors:  D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

10.  Activation of the alternate complement pathway by autologous red cell stroma.

Authors:  T R Poskitt; H P Fortwengler; B J Lunskis
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  9 in total

1.  Inhibition of cell-free oxidative bactericidal activity by erythrocytes and hemoglobin.

Authors:  W L Hand
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

2.  Nature of complement deficiency in sickle cell disease.

Authors:  W A Wilson
Journal:  Arch Dis Child       Date:  1983-03       Impact factor: 3.791

3.  Changes in the haemolytic activity of serum complement during acute Babesia bovis infection in cattle.

Authors:  D F Mahoney; I G Wright; B V Goodger
Journal:  Z Parasitenkd       Date:  1980

4.  Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients.

Authors:  R H Wang; G Phillips; M E Medof; C Mold
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

5.  Multiple organ failure after mitral valve repair with intravascular hemolysis and its recovery due to mitral valve replacement.

Authors:  M Seyr; W Hasibeder; W Furtwaegler; H Antretter; N J Mutz
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

6.  Hyperlipidemia in acute hemolysis.

Authors:  W Druml; G Grimm; A N Laggner; B Schneeweiss; K Lenz
Journal:  Klin Wochenschr       Date:  1991-07-22

7.  Vascular problems in paroxysmal nocturnal haemoglobinuria. A report of two cases.

Authors:  E Vellenga; N H Mulder; C H Gips; R A Krom
Journal:  Blut       Date:  1982-10

Review 8.  Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy.

Authors:  Dongsheng Duan
Journal:  Mol Ther       Date:  2018-07-17       Impact factor: 11.454

Review 9.  Life-Threatening Infectious Complications in Sickle Cell Disease: A Concise Narrative Review.

Authors:  Dominik Ochocinski; Mansi Dalal; L Vandy Black; Silvana Carr; Judy Lew; Kevin Sullivan; Niranjan Kissoon
Journal:  Front Pediatr       Date:  2020-02-20       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.